BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 14967736)

  • 41. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
    Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
    Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
    Cao W; Li F; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide inhibits the expression of proto-oncogene c-fos induced by angiotensin II and endothelin-1 in cardiomyocytes.
    Zhan CD; Pan JY
    Sheng Li Xue Bao; 2000 Dec; 52(6):450-4. PubMed ID: 11941405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
    Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of transcription factor AP-1 and mitogen-activated protein kinases in aniline-induced splenic toxicity.
    Khan MF; Kannan S; Wang J
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):86-93. PubMed ID: 16169568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
    Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
    Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration.
    Albinger-Hegyi A; Hegyi I; Nagy I; Bodmer M; Schmid S; Bodmer D
    Neuroscience; 2006 Feb; 137(3):971-80. PubMed ID: 16338090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
    Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
    J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
    Grau R; Punzón C; Fresno M; Iñiguez MA
    Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidant-induced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes.
    Peng M; Huang L; Xie ZJ; Huang WH; Askari A
    Cell Mol Biol Res; 1995; 41(3):189-97. PubMed ID: 8589759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
    Frigo DE; Tang Y; Beckman BS; Scandurro AB; Alam J; Burow ME; McLachlan JA
    Carcinogenesis; 2004 Feb; 25(2):249-61. PubMed ID: 14604893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.
    Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD
    Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells.
    Iwashima Y; Eto M; Horiuchi S; Sano H
    Biochem Biophys Res Commun; 1999 Oct; 264(2):441-8. PubMed ID: 10529383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.